Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Nichol

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Cancer|November 22, 2019
The impact of new systemic therapies on survival and time on hormonal treatment in hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: A population-based study in British Columbia from 2003 to 2013Dan Le, Caroline Speers, Leigh Thompson, et al.
The British Journal of Radiology|April 25, 2019
Dose-painted volumetric modulated arc therapy of high-grade glioma using 3,4-dihydroxy-6-[<sup>18</sup>F]fluoro-L-phenylalanine positron emission tomographyRobert Kosztyla, Srinivas Raman, Vitali Moiseenko, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
EGFR mutation status on brain metastases from non-small cell lung cancerFred Hsu, Alex De Caluwe, David Anderson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Outcomes of node-negative breast cancer 5 centimeters and larger treated with and without postmastectomy radiotherapyJennifer Goulart, Pauline Truong, Ryan Woods, et al.
Breast (Edinburgh, Scotland)|February 4, 2026
Large-scale DNA organization analysis of primary breast cancers for prediction of axillary lymph node metastasesNikolay Alabi, Alan Nichol, Fumiya Inaba, et al.
Radiation Oncology (London, England)|January 11, 2013
Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab erasIrene Karam, Sarah Hamilton, Alan Nichol, et al.
Journal of Geriatric Oncology|August 28, 2025
Causes of death in older patients with high-risk breast cancer: What are the most significant contributors?Hong Li, Lovedeep Gondara, Caroline Speers, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Root Cause Analysis of Omissions and Delays in the Initiation of Neoadjuvant Chemotherapy in Eligible Patients with Breast Cancer in British Columbia, CanadaJonathan L H Chan, Jaimie J Lee, Hyejee Ohm, et al.
Advances in Radiation Oncology|January 23, 2024
Toward a Skin Dose-Area Metric Predictive of Moist Desquamation Using In Vivo Skin Dosimetry and Skin AssessmentsAria Malhotra, Emilie E Carpentier, Sheri Grahame, et al.
American Journal of Surgery|March 9, 2020
Do surgeons convey all the details? A provincial assessment of operative reporting for breast cancerClaire Liu, Rona Cheifetz, Carl Brown, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Cancer|November 22, 2019
The impact of new systemic therapies on survival and time on hormonal treatment in hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: A population-based study in British Columbia from 2003 to 2013Dan Le, Caroline Speers, Leigh Thompson, et al.
The British Journal of Radiology|April 25, 2019
Dose-painted volumetric modulated arc therapy of high-grade glioma using 3,4-dihydroxy-6-[<sup>18</sup>F]fluoro-L-phenylalanine positron emission tomographyRobert Kosztyla, Srinivas Raman, Vitali Moiseenko, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
EGFR mutation status on brain metastases from non-small cell lung cancerFred Hsu, Alex De Caluwe, David Anderson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Outcomes of node-negative breast cancer 5 centimeters and larger treated with and without postmastectomy radiotherapyJennifer Goulart, Pauline Truong, Ryan Woods, et al.
Breast (Edinburgh, Scotland)|February 4, 2026
Large-scale DNA organization analysis of primary breast cancers for prediction of axillary lymph node metastasesNikolay Alabi, Alan Nichol, Fumiya Inaba, et al.
Radiation Oncology (London, England)|January 11, 2013
Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab erasIrene Karam, Sarah Hamilton, Alan Nichol, et al.
Journal of Geriatric Oncology|August 28, 2025
Causes of death in older patients with high-risk breast cancer: What are the most significant contributors?Hong Li, Lovedeep Gondara, Caroline Speers, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Root Cause Analysis of Omissions and Delays in the Initiation of Neoadjuvant Chemotherapy in Eligible Patients with Breast Cancer in British Columbia, CanadaJonathan L H Chan, Jaimie J Lee, Hyejee Ohm, et al.
Advances in Radiation Oncology|January 23, 2024
Toward a Skin Dose-Area Metric Predictive of Moist Desquamation Using In Vivo Skin Dosimetry and Skin AssessmentsAria Malhotra, Emilie E Carpentier, Sheri Grahame, et al.
American Journal of Surgery|March 9, 2020
Do surgeons convey all the details? A provincial assessment of operative reporting for breast cancerClaire Liu, Rona Cheifetz, Carl Brown, et al.
Pageof 8